Aortic Dissection
Recent clinical, regulatory, research and industry developments relating to this disease.
A population-based study of cardiovascular disease mortality risk in US cancer patients.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 4 clinical trials expected to report results, the earliest in Q4 2026.
- 1 industry development reported.
- Q4 2026Changes in Antibacterial Therapy Based on Perioperative Dynamics of Presepsin During Reconstructive Thoracic Aorta Surgery
- Q3 2027A Randomized, Double-blind, Placebo-controlled, Study to Identify the Opioid-sparing Effects, and Pain-reduction Potential of Low Dose Ketamine on Patients Undergoing TEVAR Procedures Receiving NCI
- Q3 2027Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection -A Single-Center, Randomized, Double-Blind, Controlled Clinical Trial
- Q4 2031Creation of a Digital Twin for Predicting the Progression of Patients With Chronic Thoracic Aortic Dissection
Clinical MilestonesViewHide
- 2026-06-23Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection -A Single-Center, Randomized, Double-Blind, Controlled Clinical TrialResults expected Q3 2027
- 2026-01-29Changes in Antibacterial Therapy Based on Perioperative Dynamics of Presepsin During Reconstructive Thoracic Aorta SurgeryResults expected Q4 2026
- 2026-01-02Creation of a Digital Twin for Predicting the Progression of Patients With Chronic Thoracic Aortic DissectionResults expected Q4 2031
- 2025-10-20A Randomized, Double-blind, Placebo-controlled, Study to Identify the Opioid-sparing Effects, and Pain-reduction Potential of Low Dose Ketamine on Patients Undergoing TEVAR Procedures Receiving NCIResults expected Q3 2027
- 2026-02-02Efficacy of Nitric Oxide Administration for Reducing the Risk of Acute Kidney Injury in Patients With Acute Type A Aortic Dissection: a Randomized Controlled TrialCompleted
- 2025-12-31Protective Effect of Sivelestat Against Negative Pulmonary Function and Organ Dysfunction After Cardiovascular Surgery (PANDA VI)Primary completion
- 2025-12-31Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)Primary completion
Industry & MarketViewHide
- 2026-07-15Graham’s death from aortic dissection raises questions about preventing the rare disorderIndustry · STAT News
- 2026-07-15IndustryGraham’s death from aortic dissection raises questions about preventing the rare disorderIndustry · STAT News
- 2026-06-23ClinicalStudy on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection -A Single-Center, Randomized, Double-Blind, Controlled Clinical TrialResults expected Q3 2027
- 2026-02-02ClinicalEfficacy of Nitric Oxide Administration for Reducing the Risk of Acute Kidney Injury in Patients With Acute Type A Aortic Dissection: a Randomized Controlled TrialCompleted
- 2026-01-29ClinicalChanges in Antibacterial Therapy Based on Perioperative Dynamics of Presepsin During Reconstructive Thoracic Aorta SurgeryResults expected Q4 2026
- 2026-01-02ClinicalCreation of a Digital Twin for Predicting the Progression of Patients With Chronic Thoracic Aortic DissectionResults expected Q4 2031
- 2025-12-31ClinicalProtective Effect of Sivelestat Against Negative Pulmonary Function and Organ Dysfunction After Cardiovascular Surgery (PANDA VI)Primary completion
- 2025-12-31ClinicalProtective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)Primary completion
- 2025-10-20ClinicalA Randomized, Double-blind, Placebo-controlled, Study to Identify the Opioid-sparing Effects, and Pain-reduction Potential of Low Dose Ketamine on Patients Undergoing TEVAR Procedures Receiving NCIResults expected Q3 2027
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes2
- Aorta, Abdominal1
- Aorta, Thoracic1
Leading journals1
- European heart journal2
Leading researchers8
- Aboyans V1
- Allmen RS1
- Bartolomeo RD1
- Bluethmann SM1
- Boileau C1
- Bossone E1
- Deng L1
- Eggebrecht H1
Affiliations (unnormalised)6
- Icahn School of Medicine at Mount Sinai1
- Jacobi Medical Center1
- Mayo Clinic1
- National Institutes of Health1
- Penn State Cancer Institute1
- Penn State College of Medicine1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Reference
Authoritative identity, definition & identifiers.
A tear in the inner layer of the AORTA leading to interstitial HEMORRHAGE, and splitting (dissecting) of the aortic TUNICA MEDIA layer. It typically begins with a tear in the TUNICA INTIMA layer.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.